Cryptotanshinone induces reactive oxygen species‑mediated apoptosis in human rheumatoid arthritis fibroblast‑like synoviocytes

Introduction

Rheumatoid arthritis (RA) is a common systemic and autoimmune inflammatory disease of the joints, characterized by inflammation, synovial hyperplasia and abnormal immune responses (1-3). Fibroblast-like synoviocytes (FLSs) in the RA synovium (referred to as RA-FLSs) may affect the vascular endothelium (4). Furthermore, accumulating evidence has suggested that RA-FLSs serve crucial roles in the destruction process of the joints and the development of RA (5-7). RA-FLSs have aggressive properties similar to those exhibited by cancer cells, including hyperproliferation, defective apoptosis and invasiveness (8). Thus, the prevention of RA-FLS proliferation and induction of apoptosis may be an effective therapeutic strategy for the treatment of RA.

Protein kinase B (Akt) is a serine/threonine kinase and downstream effector of phosphoinositide 3-kinase (PI3K). Activated PI3K increases the intracellular content of phosphatidylinoside-4,5-diphosphate and phosphati-dylinoside-3,4,5-triphosphate, positively inducing Akt phosphorylation (9). The mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 signaling pathways are constructed around a three-tiered phosphorylation cascade. The MAPK signaling pathway-associated proteins are known to be involved in the mediation of inflammation, and serve a critical role in the excessive proliferation and invasion of synovial fibroblasts of RA (10-12). Janus kinase (JAK) activation leads to the activation of downstream substrates and of signal transducer and activator of transcription (STAT) proteins, followed by their nuclear translocation and subsequent activation of target genes (13). The STAT3 signaling pathway is responsible for transmitting the outer signals of the cell to the nucleus and expressing the effects of biological stimulation through the induction of target gene transcription. Dysfunctional JAK/STAT signaling has been implicated in various hematological and immunological disorders, as well as other pathological inflammatory conditions (14-16). Reactive oxygen species (ROS), including oxygen ions, peroxides and oxygen-free radicals, are the main molecules that the body produces during oxidative stress. Highly reactive oxygen-free radicals are considered to be involved in the pathogenesis of RA (17-21).

The use of traditional Chinese medicine is promising for adjuvant therapy due to the low cost and low toxicity of the formulations used (22). Cryptotanshinone (CT) is a fat-soluble anthraquinone derivative and a major tanshinone found in Salvia miltiorrhiza Bunge (Lamiaceae) (17). It has a wide range of pharmacological properties, such as antitumor, anti-bacterial and anti-inflammatory properties (22-25). A number of studies have reported that CT inhibits the growth of certain types of cancer cells or induces cancer cell apoptosis, including in lung, breast and prostate cancer (26-29). However, the effects of CT on the proliferation and apoptosis of RA-FLSs, and the underlying molecular mechanisms remain unclear.

In the present study, the effects of CT on RA-FLS proliferation and apoptosis were evaluated, and the associated molecular pathways were examined. In addition, the roles of the MAPK, Akt and STAT3 signaling pathways associated with ROS generation were investigated in RA-FLSs.

Materials and methods

Chemicals and reagents

CT (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was dissolved (20 mM CT in 100% dimethyl sulfoxide) to obtain a stock solution and stored at −20°C. The stock solution was diluted with cell culture media prior to further use.

Patients and samples

Informed consent was obtained from RA patients prior to inclusion in the present study, and the procedure was approved by the Ethical Committee of the Fifth Affiliated Hospital of Harbin Medical University (Daqing, China). Synovial tissue samples were obtained from RA patients (including 3 females and 3 males aged 53-66 years) undergoing synovectomy or joint replacement in the Fifth Affiliated Hospital of Harbin Medical University. The synovial tissues were minced into small pieces and digested with 2 mg/ml collagenase type I at 37°C for 4 h. Subsequent to the enzymatic dispersion of synovial tissues, synovial cells were pelleted by centrifugation (1,200 × g for 3 min at room temperature) and cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37°C in a humidified atmosphere containing 5% CO2. After 24 h of incubation, the adherent cells were collected and cultured in DMEM, and are referred to as the primary RA-FLS cells.

Cell lines and culture

The HFLS-RA (cat. no. CBR130803), MH7A (cat. no. CBR130742) and normal synovial HFLS (cat. no. CBR130948) cells were purchased from Saiqi Biological Engineering Co., Ltd. (Shanghai, China). Cells were cultured in DMEM supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 100 µg/ml penicillin and 100 U/ml streptomycin in a humidified 5% CO2 incubator at 37°C.

Cell Counting kit-8 (CCK-8) proliferation test

Primary RA-FLS, HFLS-RA, MH7A and HFLS cells were seeded on 96-well plates (1×104 cells/well) and treated with different concentrations of CT (1, 3, 10, 30 and 100 µmol/l) for 24 h. Prior to proliferation detection, 10 µl CCK-8 reagent (Beyotime Institute of Biotechnology, Shanghai, China) was added into each well and incubated at 37°C for 1.5 h. Finally, the absorbance was measured by a microplate reader (A490) and the cell survival rates were calculated.

Fluorescence microscopy

A total of 5×105 HFLS-RA and MH7A cells/well were seeded in 6-well plates and cultured overnight. Next, the cells were treated with 5 µmol/l CT for different time durations (0, 3, 6, 12 and 24 h). According to the manufacturer’s manual that was provided with the Apoptosis Detection kit (Beyotime Institute of Biotechnology), cells were stained with 10 µl Annexin V-FITC and 5 µl propidium iodide (PI) for 15 min, and the fluorescence intensity of each sample was determined by fluorescence microscopy (Leica Microsystem, Wetzlar, Germany).

Flow cytometry

A total of 5×105 HFLS-RA were seeded in 6-well plates and cultured overnight. HFLS-RA cells were pretreated with N-acetyl cysteine (NAC, 5 mmol/l, Sigma-Aldrich; Merck KGaA) for 30 min and incubated with CT (5 µmol/l) for 24 h. Then, cells were stained with 10 µl Annexin V-FITC and 5 µl PI for 15 min, and the number of apoptotic cells were detected by flow cytometry (Beckman Coulter, Inc., Brea, CA, USA).

In order to measure the ROS levels, HFLS-RA cells were treated with CT (5 µmol/l) for 0, 3, 6, 12 and 24 h, following which the cells were incubated with 2′,7′-dichlorofluorescein-diacetate (DCFH-DA; Merck, Shanghai, China) for 30 min at 37°C. Next, cells were washed 2-3 times with PBS and harvested by centrifugation at 1,200 × g for 5 min at room temperature. The intracellular ROS levels were subsequently analyzed by flow cytometry.

Western blot analysis

Cells were lysed in ice-cold radioimmunoprecipitation buffer (50 mmol/l Tris (pH 7.4), 150 mmol/l NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 20 mg/ml AEBSF, 0.5 mg/ml pepstatin, 0.5 mg/ml leupeptin and 2 mg/ml aprotinin; (Beyotime Institute of Biotechnology) at 4°C for 30 min by shaking every 5 min and then separated by centrifugation at 4°C and 12,000 × g for 30 min. The protein concentrations were determined using Bradford reagent (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Next, 5X buffer was added to the total supernatants (30 µg), and proteins were resolved by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Subsequently, the proteins were transferred to nitrocellulose (NC) membranes, which were blocked in 5% skim milk for 2 h at room temperature. The NC membranes were then incubated overnight at 4°C with the following primary antibodies (all purchased from Santa Cruz Biotechnology, Inc., Dallas, TX, USA): Mouse monoclonal antibodies against α-tubulin (1:2,500; cat. no. sc-8035), B-cell lymphoma 2 (Bcl-2; 1:1,500; cat. no. sc-7382), Bcl-2-associated death promoter (Bad; 1:1,500; cat. no. sc-8044), cleaved caspase-3 (1:1,500; cat. no. sc-373730), cleaved poly (ADP-ribose) polymerase (PARP; 1:1,500; cat. no. sc-8007), phosphorylated ERK [p-ERK (Tyr 204); 1:1,500; cat. no. sc-8059], p-JNK (Thr 183 and Tyr 185, 1:1,500; cat. no. sc-6254), JNK (1:1,500; cat. no. sc-7345), p-p38 (1:1,500; cat. no. sc-7973), p-STAT3 (Tyr 705, 1:1,500; cat. no. sc-8059) and STAT3 (1:1,500; cat. no. sc-8019); and rabbit polyclonal antibodies against ERK2 (1:1,500; cat. no. sc-154), p38α/β (1:1,500; cat. no. sc-7972), Akt1/2/3 (1:1,500; cat. no. sc-8312) and p-Akt1/2/3 (Ser 473, 1:2,500; cat. no. sc-7985-R). Following washing with Tris-buffered saline/Tween 20 (TBST), the NC membranes were incubated with horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG (1:5,000; cat. no. ZB-2301) and goat anti-rat IgG (1:5,000; cat. no. ZB-2305) were used as secondary antibodies for 2 h at room temperature. After the membranes were washed again with TBST, an enhanced chemiluminescence reagent (Thermo Fisher Scientific, Inc.) was used to detect the relative intensities of proteins using Amersham imager 600 (AI600; GE Healthcare, Chicago, IL, USA). The band intensities were analyzed by ImageJ software (National Institutes of Health, Bethesda, MD, USA), and the relative intensity of protein expression levels was calculated by SPSS version 18.0 statistical software (SPSS, Inc., Chicago, IL, USA).

Statistical analysis

Data are presented as the mean ± standard deviation, and all the experiments were replicated three times. Continuous data were analyzed by one-way analysis of variance followed by Tukey’s post hoc tests using SPSS version 18.0 statistical software. P<0.05 was considered to indicate a difference that was statistically significant.

Results

CT exhibits cytotoxic effects in primary RA-FLS, HFLS-RA and MH7A cells

To determine the effects of CT on RA-FLS survival, primary RA-FLS, HFLS-RA, MH7A and normal HFLS cells were treated with different concentrations of CT (1, 3, 10, 30 and 100 µmol/l) for 24 h, and the cell viabilities were evaluated by the CCK-8 assay. As shown in Fig. 1A-C, CT significantly decreased the viabilities of primary RA-FLS, HFLS-RA and MH7A cells in a dose-dependent manner. The half maximal inhibitory concentration (IC50) values of primary RA-FLS, HFLS-RA and MH7A cells were 6.69±0.97, 2.56±0.42 and 7.10±0.94 µmol/l, respectively. Furthermore, CT exhibited low cytotoxic effects on HFLS cells, which had an IC50 value >100 µmol/l; however, significance was observed compared with the control (Fig. 1D).

Figure 1 Effects of CT on the proliferation of primary RA-FLS, HFLS-RA, MH7A and HFLS cells. Cells were treated with different concentrations of CT (0, 1, 3, 10, 30 and 100 µmol/l) for 24 h, following which the cell viability was evaluated by a Cell Counting kit-8 assay. The cytotoxic effects of CT on (A) Primary RA-FLS, (B) HFLS-RA, (C) MH7A and (D) HFLS cell viability are displayed. *P<0.05 and ***P<0.001, vs. control (0 µmol/l CT) group. CT, cryptotanshinone.

CT induces apoptosis by regulating the mitochondrial pathways in HFLS-RA cells

To determine whether CT induced apoptosis in RA-FLSs, HFLS-RA and MH7A cells were treated with 5 µmol/l CT for different time points (0, 3, 6, 12 and 24 h), and apoptosis was examined by Annexin V-FITC/PI double staining and flow cytometry. As shown in Fig. 2A-D, the fluorescence intensity significantly increased with the increase in the duration of CT treatment. In addition, apoptosis gradually increased in HFLS-RA and MH7A cells in a time-dependent manner (Fig. 2E-H). These results suggest that CT may be a potential inducer of apop-tosis in RA-FLSs.

Figure 2 Effects of CT on the apoptosis of HFLS-RA and MH7A cells. Cells were treated with 5 µmol/l CT for different time durations (0, 3, 6, 12 and 24 h). (A) Fluorescence microscopic images (magnification, ×400; scale bars, 200 µm) and (B) quantified fluorescence intensity of HFLS-RA cells stained with Annexin V-FITC/PI. (C) Fluorescence microscopic images (magnification, ×400; scale bars, 200 µm) and (D) quantified fluorescence intensity of MH7A cells stained with Annexin V-FITC/PI. (E) Flow cytometry results and (F) quantified cell apoptosis rate in HFLS-RA cells subsequent to staining with Annexin V-FITC/PI. (G) Flow cytometry results and (H) quantified cell apoptosis rate in MH7A cells subsequent to staining with Annexin V-FITC/PI. *P<0.05, **P<0.01 and ***P<0.001, vs. control (0 h) group. CT, cryptotanshinone.

CT-induced apoptosis was more notable in HFLS-RA cells compared with in MH7A cells; thus, HFLS-RA cells were used as the representative RA-FLS cells in subsequent experiments. As shown in Fig. 3A and B, CT treatment markedly downregulated the expression of Bcl-2, while it upregulated the protein expression levels of Bad, cleaved caspase-3 and cleaved PARP. These results revealed that CT induced apoptosis through the mitochondrial pathway.

Figure 3 CT induced apoptosis by regulating the mitochondrial pathway in HFLS-RA cells. Cells were treated with 5 µmol/l CT for various time durations (0, 3, 6, 12 and 24 h). (A) Western blot analysis results and (B) quantified protein expression levels of Bcl-2, Bad, cleaved caspase-3 and cleaved PARP in HFLS-RA cells. *P<0.05, **P<0.01 and ***P<0.001, vs. control (0 h) group. CT, cryptotanshinone; Bcl-2, B-cell lymphoma 2; Bad, Bcl-2-associated death promoter; PARP, poly (ADP-ribose) polymerase.

CT induces apoptosis by regulating the MAPK, Akt and STAT3 signaling pathways in HFLS-RA cells

To determine whether CT induced apoptosis by regulating the Akt, MAPK and STAT3 signaling pathways, HFLS-RA cells were treated with 5 µmol/l CT for different time points (0, 3, 6, 12 and 24 h), and protein expression levels were detected by western blotting. As shown in Fig. 4A and B, CT exposure increased the protein expression levels of p-p38 and p-JNK, and downregulated the expression levels of p-Akt, p-ERK and p-STAT3, in a time-dependent manner. These results revealed that CT induced apoptosis in HFLS-RA cells via the MAPK, Akt and STAT3 signaling pathways.

Figure 4 CT induced apoptosis by regulating the Akt, mitogen-activated protein kinase and STAT3 signaling pathways in HFLS-RA cells. Cells were treated with 5 µmol/l CT for various time durations (0, 3, 6, 12 and 24 h). (A) Western blot analysis results and (B) quantified protein expression levels of Akt, p38, JNK, ERK and STAT3. **P<0.01 and ***P<0.001, vs. control (0 h) group. CT, cryptotanshinone; Akt, protein kinase B; JNK, c-Jun N-terminal kinase; ERK, extracellular signal-regulated kinase; STAT3, signal transducer and activator of transcription-3; p-, phosphorylated.

CT induces apoptosis by regulating intracellular ROS levels in HFLS-RA cells

To determine whether CT induced intracellular ROS generation, the HFLS-RA cells were treated with 5 µmol/l CT for different durations (0, 3, 6, 12 and 24 h), after which the levels of ROS were detected by flow cytom-etry. As shown in Fig. 5A and B, CT treatment significantly increased ROS generation in a time-dependent manner.

Figure 5 CT induced apoptosis via ROS-mediated signaling pathways in HFLS-RA cells. (A) Flow cytometry and (B) quantified levels of intracellular ROS in HFLS-RA cells incubated with 5 µmol/l CT for the indicated time durations (0, 3, 6, 12 and 24 h) and then stained with DCFH-DA (10 µmol/l) for 30 min. (C) Flow cytometry and (D) quantification of apoptosis in HFLS-RA cells pretreated with NAC (100 µmol/l) for 30 min and then stimulated with 5 µmol/l CT for 24 h. (E) Western blot analysis and (F) quantified protein expression levels of Bcl-2, Bad, cleaved caspase-3 and cleaved PARP in HFLS-RA cells treated with NAC (100 µmol/l) and/or 5 µmol/l CT. **P<0.01 and ***P<0.001, vs. untreated control group. CT, cryptotanshinone; ROS, reactive oxygen species; NAC, N-acetyl cysteine; Bcl-2, B-cell lymphoma 2; Bad, Bcl-2-associated death promoter; PARP, poly (ADP-ribose) polymerase.

To further investigate whether CT-induced apoptosis was mediated by intracellular ROS, the cells were divided into four groups, as follows: Control, CT, NAC and CT+NAC. As shown in Fig. 5C and D, CT-induced apoptosis was significantly suppressed after scavenging of intracellular ROS by treatment with NAC. Changes in the expression levels of apoptosis-associated proteins were detected by western blotting, which demonstrated that the expression levels of Bcl-2, Bad, cleaved caspase-3 and cleaved PARP were recovered following intracellular ROS scavenging (Fig. 5E and F). These results indicated that the increased levels of ROS were involved in CT-induced apoptosis.

CT induces apoptosis through ROS-mediated Akt, MAPK and STAT3 signaling pathways in HFLS-RA cells

To investigate whether CT induced apoptosis through regulating ROS-mediated Akt, MAPK and STAT3 signaling pathways, HFLS-RA cells were cultured overnight, treated with CT or NAC for 24 h, and divided into four groups as follows: Control, CT, NAC and CT+NAC. Next, the protein expression levels were detected by western blotting. As shown in Fig. 6A and B, as compared with the CT treatment group, upregulation of p-Akt, p-ERK and p-STAT3 levels, and downregulation of p-p38 and p-JNK were detected in the CT+NAC treatment group. These data indicated that CT induced apoptosis through ROS-mediated MAPK, Akt and STAT3 signaling pathways.

Figure 6 CT induced ROS-mediated apoptosis via the Akt, mitogen-activated protein kinase and STAT3 signaling pathways. Cells were pretreated with NAC (100 µmol/l) for 30 min and then stimulated with 5 µmol/l CT for 24 h. (A) Western blots and (B) quantified protein expression levels of Akt, p38, JNK, ERK and STAT3 are shown. **P<0.01 and ***P<0.001, vs. untreated control group. CT, cryptotanshinone; ROS, reactive oxygen species; NAC, N-acetyl cysteine; Akt, protein kinase B; JNK, c-Jun N-terminal kinase; ERK, extracellular signal-regulated kinase; STAT3, signal transducer and activator of transcription-3; p-, phosphorylated.

Discussion

RA-FLSs are characterized by the massive imbalance between excessive cell proliferation and apoptosis, and induced cells apoptosis may be a possible treatment for patients with RA (30). Apoptosis is regulated by the mitochondrial pathway via the imbalance of pro-apoptotic (such as Bad) and anti-apoptotic proteins (such as Bcl-2) (31). Caspase-3 is the key executive mediator of apoptosis and a common downstream effector of a number of apoptotic signaling pathways (32). The present study demonstrated that the anti-proliferative and pro-apoptotic effects of CT in primary RA-FLS, HFLS-RA and MH7A cells. In addition, the results revealed that the CT-mediated apoptosis of RA-FLSs may be causally linked to the upregulation of the pro-apoptotic protein Bad and downregulation of the anti-apoptotic protein Bcl-2, as well as the activation of caspase-3 and PARP. These findings indicated that activation of the caspase cascade contributed to the apoptosis of RA-FLSs.

The Akt signaling pathway generally restrains chondrogenesis and apoptosis mediated by Akt, and has been considered a potential target for RA treatment (33). In addition, the MAPK signaling pathway controls the proliferation, differentiation, survival and migration of various cell types, thereby serving a crucial role in cell differentiation, apoptosis, stress response, and occurrence and development of various human diseases (34,35). Thus, blocking the MAPK signaling pathway as a tool for identifying a novel drug for RA treatment has been the focus of certain research studies (36,37). Furthermore, the STAT3 signaling pathway is a signal transduction pathway that was identified in recent years to function in response to cytokine stimulation. It participates in numerous important biological processes, such as cell proliferation, differentiation, apoptosis and immune regulation (38). STAT3 has also been detected in the synovial lining of RA patients and animal models of RA, and STAT3 blockade promoted apoptosis in RA-FLSs (39). In the current study, the molecular mechanisms underlying CT-induced apoptosis were evaluated, and the results indicated that CT decreased the expression levels of Akt, ERK and STAT3, and increased the expression levels of JNK and p38. Thus, CT induced apoptosis via the Akt, MAPK and STAT3 signaling pathways in HFLS-RA cells.

ROS is a group of highly reactive molecular oxygen species produced by mitochondrial respiration, including oxygen ions, hydrogen peroxide and oxygen-free radicals (17). ROS generation is considered to be one of the primary cytotoxic mechanisms that induce cell apoptosis or necrosis (19). In normal conditions, high levels of ROS are involved in the pathogenesis of RA and may be an important mechanism for cell death (40). The results of the present study demonstrated that CT increased the levels of ROS, which led to an increase in the number of apoptotic cells, while apoptosis was suppressed by intracellular ROS scavenging. In addition, the Akt, MAPK and STAT3 signaling pathways were rescued after the scavenging of intracellular ROS. These results revealed that CT-induced apoptosis was regulated by ROS-mediated Akt, MAPK and STAT3 signaling pathways in HFLS-RA cells. In future research, the effects of CT in vivo should be evaluated.

In conclusion, the results of the present study demonstrated the mechanisms underlying the function of CT in HFLS-RA cells. Specifically, CT inhibited the proliferation and induced the apoptosis of HFLS-RA cells through ROS-mediated Akt, MAPK and STAT3 signaling pathways. These data provide evidence that CT may be a potential therapeutic agent for the treatment of RA.

Funding

The present study was funded by the Multigrain Production And Processing Characteristic Discipline Construction Project (grant no. 2042070010), the Natural Science Foundation of Heilongjiang Province of China (grant no. LC2015036) and the Postdoctoral Scientific Research Foundation of Heilongjiang Province of China (grant no. LBH-Q13132).

Availability of data and materials

The analyzed datasets generated during the study are available from the corresponding author on reasonable request.

Authors’ contributions

HNS, YHL, LQM, DJZ and CHJ conceived and designed the experiments. HNS, YHL and LQM performed the experiments. XJP, YW, JRW, HW, YiZ, JQL, WTX and YL performed the CCK-8 assay. YuZ, TZ, YHH and MHJ performed sample preparations for western blotting. GNS, YQZ and LKC performed sample preparations for flow cytometry. DJZ and CHJ wrote the paper. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The present study was approved by the Ethical Committee of the Fifth Affiliated Hospital of Harbin Medical University (Daqing, China). Written informed consent was obtained from each patient involved in the current study.

Patient consent for publication

Consent for publication was obtained from the participants.

Competing interests

The authors declare that they have no competing interests.

Acknowledgments

Not applicable.

References